ALG3 Is a Potential Biomarker for the Prognosis of Bladder Cancer

被引：1
作者：
Li, Ming [1 ]
Zhang, Ning [2 ]
Shan, Weimin [1 ]
Guan, Bo [1 ]
机构：
[1] Fuyang Peoples Hosp, Dept Urol, 501 Sanqing Rd, Fuyang 236000, Peoples R China
[2] Lianyungang Higher Vocat Coll Tradit Chinese Med, Dept Med Nursing, Lianyungang, Peoples R China
来源：
ANNALS OF CLINICAL AND LABORATORY SCIENCE | 2022年 / 52卷 / 01期
关键词：
ALG3; bladder cancer; prognosis; proliferation; MALIGNANT PHENOTYPES; EPIDEMIOLOGY; REPRESSES;
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
Objective. Previous research showed that ALG3 was associated with several cancers, but the function of ALG3 in bladder cancer (BC) was yet unknown. The purpose of this study was to investigate the relative expression of ALG3 in BC tissues and corresponding normal tissues and the relationship between the relative expression of ALG3 and clinical outcome in bladder cancer patients. Methods. In this study, the expression of ALG3 in bladder cancer was detected by immunochemistry. In order to determine the cell proliferation and migration ability more accurately, we performed colony forming assay, MTT assay and wound healing migration assay. The role of ALG3 on tumor growth and metastasis was explored by animal model in vivo. Results. ALG3 was expressed higher in bladder cancer than that in the normal tissues (P<0.05). At the same time, we found that there was a positive correlation between ALG3 expression and the prognosis (P<0.05). Moreover, we also discovered that the expression of ALG3 was associated with clinical pathological features (P<0.05). The proliferation and migration abilities of bladder cancer cell line T24 and 5637 were inhibited by silencing ALG3. In addition, the growth of bladder cancer cell line T24 cells were inhibited by silencing ALG3 in vivo. Conclusion. Silencing ALG3 plays a critical role in bladder cancer development and growth. It inhibits bladder cancer cells growth in vitro and in vivo.
引用
收藏
页码：117 / 125
页数：9
相关论文
共 30 条
[1]   Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up [J].
Bellmunt, J. ;
Orsola, A. ;
Leow, J. J. ;
Wiegel, T. ;
De Santis, M. ;
Horwich, A. .
ANNALS OF ONCOLOGY, 2014, 25 :40-48
[2]   Epidemiology and Risk Factors of Urothelial Bladder Cancer [J].
Burger, Maximilian ;
Catto, James W. F. ;
Dalbagni, Guido ;
Grossman, H. Barton ;
Herr, Harry ;
Karakiewicz, Pierre ;
Kassouf, Wassim ;
Kiemeney, Lambertus A. ;
La Vecchia, Carlo ;
Shariat, Shahrokh ;
Lotan, Yair .
EUROPEAN UROLOGY, 2013, 63 (02) :234-241
[3]   Increased lncRNA ABHD11-AS1 represses the malignant phenotypes of bladder cancer [J].
Chen, Mingwei ;
Li, Jianfa ;
Zhuang, Chengle ;
Cai, Zhiming .
ONCOTARGET, 2017, 8 (17) :28176-28186
[4]   Tetracycline-inducible shRNA targeting antisense long non-coding RNA HIF1A-AS2 represses the malignant phenotypes of bladder cancer [J].
Chen, Mingwei ;
Zhuang, Chengle ;
Liu, Yuchen ;
Li, Jianfa ;
Dai, Fen ;
Xia, Ming ;
Zhan, Yonghao ;
Lin, Junhao ;
Chen, Zhicong ;
He, Anbang ;
Xu, Wen ;
Zhao, Guoping ;
Guo, Yinglu ;
Cai, Zhiming ;
Huang, Weiren .
CANCER LETTERS, 2016, 376 (01) :155-164
[5]   Gene expression profiles in squamous cell cervical carcinoma using array-based comparative genomic hybridization analysis [J].
Choi, Y. -W. ;
Bae, S. M. ;
Kim, Y. -W. ;
Lee, H. N. ;
Kim, Y. W. ;
Park, T. C. ;
Ro, D. Y. ;
Shin, J. C. ;
Shin, S. J. ;
Seo, J. -S. ;
Ahn, W. S. .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2007, 17 (03) :687-696
[6]   Utility of Routine Preoperative 18F-Fluorodeoxyglucose Positron Emission Tomography/Computerized Tomography in Identifying Pathological Lymph Node Metastases at Radical Cystectomy [J].
Dason, Shawn ;
Wong, Nathan C. ;
Donahue, Timothy F. ;
Meier, Andreas ;
Zheng, Junting ;
Mannelli, Lorenzo ;
Di Paolo, Pier Luigi ;
Dean, Lucas W. ;
McPherson, Victor A. ;
Rosenberg, Jonathan E. ;
Bajorin, Dean F. ;
Capeanu, Marinella ;
Dalbagni, Guido ;
Vargas, H. Alberto ;
Bochner, Bernard H. .
JOURNAL OF UROLOGY, 2020, 204 (02) :254-258
[7]   High-Mannose Glycans are Elevated during Breast Cancer Progression [J].
de Leoz, Maria Lorna A. ;
Young, Lawrence J. T. ;
An, Hyun Joo ;
Kronewitter, Scott R. ;
Kim, Jaehan ;
Miyamoto, Suzanne ;
Borowsky, Alexander D. ;
Chew, Helen K. ;
Lebrilla, Carlito B. .
MOLECULAR & CELLULAR PROTEOMICS, 2011, 10 (01)
[8]   The prognostic value of family history among patients with urinary bladder cancer [J].
Egbers, Lieke ;
Grotenhuis, Anne J. ;
Aben, Katja K. ;
Witjes, J. Alfred ;
Kiemeney, Lambertus A. ;
Vermeulen, Sita H. .
INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (05) :1117-1124
[9]  
El-Gamal R, 2020, UROL ONCOL-SEMIN ORI, V38, DOI 10.1016/j.urolonc.2020.02.006
[10]   Natural killer cell-based adoptive immunotherapy eradicates and drives differentiation of chemoresistant bladder cancer stem-like cells [J].
Ferreira-Teixeira, Margarida ;
Paiva-Oliveira, Daniela ;
Parada, Belmiro ;
Alves, Vera ;
Sousa, Vitor ;
Chijioke, Obinna ;
Munz, Christian ;
Reis, Flavio ;
Rodrigues-Santos, Paulo ;
Gomes, Celia .
BMC MEDICINE, 2016, 14
123